168 related articles for article (PubMed ID: 18974231)
81. Steroid contents and cortical steroidogenic enzymes in non-hyperfunctioning adrenal adenoma.
Suzuki H; Shibata H; Takita T; Wakino S; Ogishima T; Ishimura Y; Saruta T
Endocr J; 1994 Jun; 41(3):267-74. PubMed ID: 7951578
[TBL] [Abstract][Full Text] [Related]
82. Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors.
Bechmann N; Moskopp ML; Constantinescu G; Stell A; Ernst A; Berthold F; Westermann F; Jiang J; Lui L; Nowak E; Zopp S; Pacak K; Peitzsch M; Schedl A; Reincke M; Beuschlein F; Bornstein SR; Fassnacht M; Eisenhofer G
J Clin Endocrinol Metab; 2024 Jan; 109(2):471-482. PubMed ID: 37647861
[TBL] [Abstract][Full Text] [Related]
83. Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy: aromatase activity, protein expression, mRNA and utilization of gonadal type promoter.
Watanabe T; Yasuda T; Noda H; Wada K; Kazukawa I; Someya T; Minamitani K; Minagawa M; Wataki K; Matsunaga T; Ohnuma N; Kohno Y; Harada N
Endocr J; 2000 Dec; 47(6):723-30. PubMed ID: 11228047
[TBL] [Abstract][Full Text] [Related]
84. Aromatase activity in an estrogen-producing adrenocortical carcinoma in a young man.
Kimura M; Itoh N; Tsukamoto T; Kumamoto Y; Takagi Y; Mori Y
J Urol; 1995 Mar; 153(3 Pt 2):1039-40. PubMed ID: 7853554
[TBL] [Abstract][Full Text] [Related]
85. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony.
Stratakis CA
Trends Endocrinol Metab; 2003 Nov; 14(9):404-10. PubMed ID: 14580759
[TBL] [Abstract][Full Text] [Related]
86. Oestrogen producing adrenocortical adenoma: clinical, biochemical and immunohistochemical studies.
Goto T; Murakami O; Sato F; Haraguchi M; Yokoyama K; Sasano H
Clin Endocrinol (Oxf); 1996 Nov; 45(5):643-8. PubMed ID: 8977764
[TBL] [Abstract][Full Text] [Related]
87. Editorial comment from Dr Fang to increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas.
Fang Y
Int J Urol; 2011 Oct; 18(10):697-9. PubMed ID: 21883494
[No Abstract] [Full Text] [Related]
88. Editorial comment from Dr Ishidoya to increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas.
Ishidoya S
Int J Urol; 2011 Oct; 18(10):697. PubMed ID: 21883493
[No Abstract] [Full Text] [Related]
89. Genomic insights into Cushing syndrome.
Assié G
Ann Endocrinol (Paris); 2018 Jun; 79(3):119-122. PubMed ID: 29735160
[TBL] [Abstract][Full Text] [Related]
90. Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
Lin SR; Tsai JH; Yang YC; Lee SC
Br J Cancer; 1998 Apr; 77(7):1060-5. PubMed ID: 9569040
[TBL] [Abstract][Full Text] [Related]
91. Cytochrome b5 expression in gonadectomy-induced adrenocortical neoplasms of the domestic ferret (Mustela putorius furo).
Wagner S; Kiupel M; Peterson RA; Heikinheimo M; Wilson DB
Vet Pathol; 2008 Jul; 45(4):439-42. PubMed ID: 18587089
[TBL] [Abstract][Full Text] [Related]
92. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.
Berthon A; Hannah-Shmouni F; Maria AG; Faucz FR; Stratakis CA
J Steroid Biochem Mol Biol; 2019 Jul; 191():105316. PubMed ID: 31014964
[TBL] [Abstract][Full Text] [Related]
93. E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.
Stratakis CA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3629-33. PubMed ID: 25279575
[No Abstract] [Full Text] [Related]
94. Estrogen-related receptor α in normal adrenal cortex and adrenocortical tumors: involvement in development and oncogenesis.
Felizola SJ; Nakamura Y; Hui XG; Satoh F; Morimoto R; M McNamara K; Midorikawa S; Suzuki S; Rainey WE; Sasano H
Mol Cell Endocrinol; 2013 Jan; 365(2):207-11. PubMed ID: 23123734
[TBL] [Abstract][Full Text] [Related]
95. Protein kinase A defects and cortisol-producing adrenal tumors.
Zilbermint M; Stratakis CA
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
[TBL] [Abstract][Full Text] [Related]
96. Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations.
Calebiro D; Bathon K; Weigand I
Horm Metab Res; 2017 Apr; 49(4):307-314. PubMed ID: 27813054
[TBL] [Abstract][Full Text] [Related]
97. Aromatase p450 expression in a feminizing adrenal adenoma presenting as isosexual precocious puberty.
Phornphutkul C; Okubo T; Wu K; Harel Z; Tracy TF; Pinar H; Chen S; Gruppuso PA; Goodwin G
J Clin Endocrinol Metab; 2001 Feb; 86(2):649-52. PubMed ID: 11158024
[TBL] [Abstract][Full Text] [Related]
98. Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas.
Nolé P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
PLoS One; 2016; 11(9):e0162379. PubMed ID: 27598485
[TBL] [Abstract][Full Text] [Related]
99. Ectopic cortisol-producing adrenocortical adenoma in the renal hilum: histopathological features and steroidogenic enzyme profile.
Tong A; Jia A; Yan S; Zhang Y; Xie Y; Liu G
Int J Clin Exp Pathol; 2014; 7(7):4415-21. PubMed ID: 25120827
[TBL] [Abstract][Full Text] [Related]
100. Lipofuscin Accumulation in Cortisol-Producing Adenomas With and Without PRKACA Mutations.
Angelousi A; Szarek E; Shram V; Kebebew E; Quezado M; Stratakis CA
Horm Metab Res; 2017 Oct; 49(10):786-792. PubMed ID: 28834963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
